[The combined immunoenzyme test: anti-HIV-1 and -2 and anti-HTLV-1 in the detection of donors with retrovirus infections].
Serums of whole blood donors, plasma donors, hemophiliacs, persons with risks behavior and normal population simultaneously were tested for markers of infectious diseases, anti-HIV-1 with Plivazim and anti-HIV-1/2 and anti-HTLV-1/2 with Roche Retrovirus EIA. The positive results were confirmed by immunofluorescence assay and Western blot. Nonspecific reactive serums were detected by Roche Retrovirus EIA and by Plivazim EIA, but there was no significant difference in the frequence of reactive results. Roche Retrovirus EIA test had specificity of 99.16% and sensibility of 97.56% as compared to Plivazim. Simultaneous testing of donors with a combined test for anti-HIV-1/2 and anti-HTLV-1 is equally reliable as testing with only anti-HIV-1.
Dobec
M
M
Institut Virion, Zürich, Svicarska.
Jung
M
M
Zupancić-Salek
S
S
Burek
V
V
Mihaljević
I
I
Grgicević
D
D
D015492:AIDS Serodiagnosis; D001782:Blood Donors; D015483:HIV Antibodies / Q000032:analysis*; D015481:HTLV-I Antibodies / Q000032:analysis*; D006467:Hemophilia A / Q000276:immunology; D006801:Humans; D007124:Immunoenzyme Techniques; D012680:Sensitivity and Specificity
D015483:HIV Antibodies; D015481:HTLV-I Antibodies
Ispitivanje kombiniranog enzimskog imunoloskog testa: anti-HIV 1/2 i anti HTLV-1 u otkrivanju davatelja zarazenih retrovirusima.